Roche: Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
Phase III study meets primary endpoint of increasing the time patients live disease free compared with commonly used chemotherapy combination
21-Jul-2009 -
Roche announced results from the international phase III study NO16968 (XELOXA), investigating oral Xeloda in combination with intravenous oxaliplatin (XELOX) immediately after surgery, which show that patients with colon cancer taking XELOX live disease free for longer compared to those taking ...
breast cancer
chemotherapy
colon cancer
+2